SLAMABODY Trademark
Trademark Overview
On Monday, July 8, 2002, a trademark application was filed for SLAMABODY with the United States Patent and Trademark Office. The USPTO has given the SLAMABODY trademark a serial number of 78142018. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Thursday, June 9, 2005. This trademark is owned by Celltech R & D, Inc.. The SLAMABODY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceuticals, namely, antibodies, antibody fragments, and antibody constructs for diagnostic, prophylactic and therapeutic use in connection with a wide range of diseases, namely, cancer, autoimmune diseases, inflammatory diseases, central nervous system diseases and osteoporosis; and pharmaceuticals, namely, pharmaceuticals containing antibodies, antibody fragments, and antibody constructs for diagnostic, prophylactic and therapeutic use in connection with a wide range of diseases, namely, cancer, autoimmune diseases, inflammatory diseases, central nervous system diseases and osteoporosis
pharmaceutical and biological product development consultation in the field of antibodies and research and development services in the field of antibodies
General Information
| Serial Number | 78142018 |
| Word Mark | SLAMABODY |
| Filing Date | Monday, July 8, 2002 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Thursday, June 9, 2005 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 16, 2004 |
Trademark Statements
| Goods and Services | Pharmaceuticals, namely, antibodies, antibody fragments, and antibody constructs for diagnostic, prophylactic and therapeutic use in connection with a wide range of diseases, namely, cancer, autoimmune diseases, inflammatory diseases, central nervous system diseases and osteoporosis; and pharmaceuticals, namely, pharmaceuticals containing antibodies, antibody fragments, and antibody constructs for diagnostic, prophylactic and therapeutic use in connection with a wide range of diseases, namely, cancer, autoimmune diseases, inflammatory diseases, central nervous system diseases and osteoporosis |
| Goods and Services | pharmaceutical and biological product development consultation in the field of antibodies and research and development services in the field of antibodies |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 12, 2002 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 12, 2002 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Celltech R & D, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Bothell, WA 98021 |
| Party Name | Celltech R & D, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Bothell, WA 98021 |
Trademark Events
| Event Date | Event Description |
| Tuesday, October 4, 2005 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Tuesday, September 27, 2005 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, December 21, 2004 | EXTENSION 1 GRANTED |
| Monday, December 6, 2004 | EXTENSION 1 FILED |
| Monday, December 6, 2004 | TEAS EXTENSION RECEIVED |
| Tuesday, June 8, 2004 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 16, 2004 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 25, 2004 | NOTICE OF PUBLICATION |
| Wednesday, January 14, 2004 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, December 26, 2003 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 26, 2003 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 30, 2003 | CASE FILE IN TICRS |
| Wednesday, November 26, 2003 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, May 27, 2003 | FINAL REFUSAL E-MAILED |
| Tuesday, April 15, 2003 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 15, 2003 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, October 21, 2002 | NON-FINAL ACTION E-MAILED |
| Thursday, October 17, 2002 | ASSIGNED TO EXAMINER |
